All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells

Cell Growth Differ. 2002 Aug;13(8):343-54.

Abstract

A comparison between retinoic acid (RA) differentiation-resistant and differentiation-sensitive SK-N-BE neuroblastoma (NB) cell lines revealed an association between resistance to differentiation, exhibited by N-myc stable transfected SK-N-BE 9N cells, with sensitivity to RA induction of p50/p65 nuclear factor kappaB (NF-kappaB) transcription factor activity and induction of matrix metalloproteinase (MMP)-9 expression leading to enhanced invasive behavior in vitro. These effects were not observed in differentiation-sensitive parental SK-N-BE or control-transfected SK-N-BE 2N counterparts. RA activated a MMP-9 promoter reporter gene construct in SK-N-BE 9N but not parental SK-N-BE or SK-N-BE 2N cells through a NF-kappaB element (-600) in association with enhanced p50 mRNA expression, reduced cytoplasmic inhibitor of nuclear factor kappaBalpha protein levels, and the induction of nuclear p50/p65 containing MMP-9 NF-kappaB site binding activity. RA activation of the MMP-9 promoter was inhibited by transient overexpression of a dominant-negative inhibitor of nuclear factor kappaBalpha protein and stimulated by transient p50 but not p65 overexpression in the absence of RA. A limited, nonessential function for activator protein 1 (-74), Ets (-540), and SP1 (-560) elements within the MMP-9 promoter was revealed by point mutation but was not associated with changes in the binding or position of complexes constitutive to differentiation-sensitive or -resistant cells. Our data indicates that in this model of NB resistance to differentiation that results from uncoupled RA regulation of N-myc expression, RA stimulates malignant NB cell behavior by inducing nuclear NF-kappaB transcription factor activity, which in turn induces MMP-9 expression and stimulation of basement membrane invasive capacity involving MMP-9 activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Basement Membrane / drug effects
  • Basement Membrane / metabolism*
  • Biocompatible Materials
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Child
  • Collagen
  • Drug Combinations
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology
  • Humans
  • I-kappa B Proteins / metabolism
  • Laminin
  • Matrix Metalloproteinase 9 / genetics*
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / genetics*
  • NF-kappa B / metabolism*
  • NF-kappa B p50 Subunit
  • Neoplasm Invasiveness / genetics*
  • Neuroblastoma / enzymology
  • Neuroblastoma / genetics*
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Proteoglycans
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Biocompatible Materials
  • Drug Combinations
  • I-kappa B Proteins
  • Laminin
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • NFKBIA protein, human
  • Proteoglycans
  • RNA, Messenger
  • matrigel
  • NF-KappaB Inhibitor alpha
  • Tretinoin
  • Collagen
  • Matrix Metalloproteinase 9